12/5
09:49 am
abcl
Animal Health Partnering Terms and Agreements Analysis Report 2024: Access 269 Deals Signed by the World's Leading Life Science Companies Since 2017 [Yahoo! Finance]
Low
Report
Animal Health Partnering Terms and Agreements Analysis Report 2024: Access 269 Deals Signed by the World's Leading Life Science Companies Since 2017 [Yahoo! Finance]
11/21
04:11 pm
abcl
AbCellera to Present at Upcoming Investor Conferences in December and January [Yahoo! Finance]
Low
Report
AbCellera to Present at Upcoming Investor Conferences in December and January [Yahoo! Finance]
11/21
04:05 pm
abcl
AbCellera to Present at Upcoming Investor Conferences in December and January
Low
Report
AbCellera to Present at Upcoming Investor Conferences in December and January
11/7
10:09 am
abcl
AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024 [Yahoo! Finance]
Low
Report
AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024 [Yahoo! Finance]
11/7
10:05 am
abcl
AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024
Low
Report
AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024
11/7
08:08 am
abcl
AbCellera Biologics Inc. (NASDAQ:ABCL) Just Reported And Analysts Have Been Cutting Their Estimates [Yahoo! Finance]
Low
Report
AbCellera Biologics Inc. (NASDAQ:ABCL) Just Reported And Analysts Have Been Cutting Their Estimates [Yahoo! Finance]
11/5
12:33 pm
abcl
AbCellera Biologics Inc. (NASDAQ: ABCL) had its "hold" rating re-affirmed by analysts at Benchmark Co..
Low
Report
AbCellera Biologics Inc. (NASDAQ: ABCL) had its "hold" rating re-affirmed by analysts at Benchmark Co..
11/5
11:20 am
abcl
AbCellera Biologics Inc. (NASDAQ: ABCL) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $12.00 price target on the stock, down previously from $14.00.
Low
Report
AbCellera Biologics Inc. (NASDAQ: ABCL) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $12.00 price target on the stock, down previously from $14.00.
11/5
02:27 am
abcl
AbCellera Biologics Inc (ABCL) Q3 2024 Earnings Call Highlights: Navigating Challenges with ... [Yahoo! Finance]
Medium
Report
AbCellera Biologics Inc (ABCL) Q3 2024 Earnings Call Highlights: Navigating Challenges with ... [Yahoo! Finance]
11/4
11:14 pm
abcl
AbCellera Biologics (ABCL) Q3 2024 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
AbCellera Biologics (ABCL) Q3 2024 Earnings Call Transcript [Yahoo! Finance]
11/4
07:54 pm
abcl
AbCellera Biologics Inc. (ABCL) Reports Q3 Loss, Misses Revenue Estimates [Yahoo! Finance]
Medium
Report
AbCellera Biologics Inc. (ABCL) Reports Q3 Loss, Misses Revenue Estimates [Yahoo! Finance]
11/4
04:05 pm
abcl
AbCellera Reports Q3 2024 Business Results
Low
Report
AbCellera Reports Q3 2024 Business Results
10/22
04:20 pm
abcl
AbCellera to Present at Upcoming Investor Conferences in November 2024 [Yahoo! Finance]
Low
Report
AbCellera to Present at Upcoming Investor Conferences in November 2024 [Yahoo! Finance]
10/22
04:05 pm
abcl
AbCellera to Present at Upcoming Investor Conferences in November 2024
Low
Report
AbCellera to Present at Upcoming Investor Conferences in November 2024
10/4
09:00 am
abcl
AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024
Low
Report
AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024
9/26
04:05 pm
abcl
AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024
Low
Report
AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024